Skip to main content
Premium Trial:

Request an Annual Quote

The 'Artist'

University of Pennsylvania chemist William DeGrado is an "artist" when it comes to creating new proteins, says Robert Langreth at Forbes' Treatments blog. His goal is to create new molecules not found in nature that can serve humanity by absorbing environmental toxins and fighting cancer, among other things, Langreth says. But while the more complicated applications of his work are years away, DeGrado's research could have immediate implications for the creation of new antibiotics to fight virulent strains of drug-resistant bacteria. "Scientists have known for decades that organisms as diverse as insects, frogs, pigs and humans make natural protein-based antibiotics to ward off microbes," Langreth says. "Drugmakers have tried to bottle their power, but the compounds, known as antimicrobial peptides, have proven to be poor drugs." Using supercomputer simulations, DeGrado has created new antibiotics that mimic natural ones, but are easier to produce. One such antibiotic is now in trials at biotech firm PolyMedix, Langreth says, and has shown to be as powerful as vancomycin in animal trials.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.